<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25429720</article-id><article-id pub-id-type="pmc">4258928</article-id><article-id pub-id-type="publisher-id">2331</article-id><article-id pub-id-type="doi">10.1186/1745-6215-15-466</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Remifentanil versus fentanyl during cardiac surgery on the incidence of chronic thoracic pain (REFLECT): study protocol for a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Hoogd</surname><given-names>Sjoerd</given-names></name><address><email>s.de.hoogd@antoniusziekenhuis.nl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ahlers</surname><given-names>Sabine JGM</given-names></name><address><email>sabineahlers@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>van Dongen</surname><given-names>Eric PA</given-names></name><address><email>h.dongen@antoniusziekenhuis.nl</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Tibboel</surname><given-names>Dick</given-names></name><address><email>j.illsley@erasmusmc.nl</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Dahan</surname><given-names>Albert</given-names></name><address><email>a.dahan@lumc.nl</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Knibbe</surname><given-names>Catherijne AJ</given-names></name><address><email>c.knibbe@antoniusziekenhuis.nl</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff1"><label/>Department of Clinical Pharmacy, St Antonius Hospital, Koekoeklaan 1, 3435 CM Nieuwegein, The Netherlands </aff><aff id="Aff2"><label/>Department of Anesthesiology and Intensive Care, St Antonius Hospital, Koekoeklaan 1, 3435 CM Nieuwegein, The Netherlands </aff><aff id="Aff3"><label/>Intensive Care and Department of Pediatric surgery, Erasmus MC - Sophia Children&#x02019;s Hospital, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands </aff><aff id="Aff4"><label/>Department of Anesthesiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands </aff><aff id="Aff5"><label/>Division of Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, Leiden, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>15</volume><elocation-id>466</elocation-id><history><date date-type="received"><day>8</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; de Hoogd et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Chronic thoracic pain after cardiac surgery is prevalent (11 to 56%) and may affect patients&#x02019; physical and mental health status. Despite its favorable pharmacokinetic and pharmacodynamic properties, high doses of remifentanil administered during surgery are reported to cause acute postoperative pain and increased requirements for analgesics. Recently, an association between remifentanil use and the incidence of chronic thoracic pain in the long term was also reported. Our objective is to investigate the influence of the intraoperative remifentanil on chronic postoperative pain in a prospective randomized controlled trial.</p></sec><sec><title>Methods/design</title><p>In this prospective, randomized, single-blind clinical trial, all patients (N =126) between 18 and 85&#x000a0;years undergoing cardiac surgery via sternotomy receive a continuous infusion of propofol together with intermittent intravenous fentanyl at predetermined times perioperatively. Patients are randomized to receive either an additional continuous infusion of remifentanil (0.15&#x000a0;&#x003bc;g<sup>-1</sup>kgIBW<sup>-1</sup>&#x000a0;min<sup>-1</sup>) or additional fentanyl (200 to 500&#x000a0;&#x003bc;g) as needed during surgery.</p><p>The primary end point is the prevalence of chronic thoracic pain 12&#x000a0;months after surgery. Secondary end points include acute postoperative pain; postoperative analgesic use; chronic thoracic pain 3 and 6&#x000a0;months after surgery; quality of life (SF-12) at 3, 6 and 12&#x000a0;months after surgery; work productivity; and use of health care. In addition, thermal detection and pain thresholds are measured preoperatively, 3&#x000a0;days after surgery and 12&#x000a0;months after surgery using quantitative sensory testing (QST). Finally, the influence of several genetic variances on the different outcomes will be measured.</p></sec><sec><title>Discussion</title><p>Chronic thoracic pain is prevalent after cardiac surgery, and research is needed to minimize the risk of chronic persistent postoperative pain, which is an invalidating, long-term complication of surgery. The objective of this trial is to determine the influence of perioperative remifentanil on long-term pain outcomes for cardiac patients in a prospective randomized trial. The results may be used to optimize perioperative analgesia techniques and, thereby, improve quality of life after cardiac surgery.</p></sec><sec><title>Trial registration</title><p>Clinicaltrials.gov
<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02031016">NCT02031016</ext-link> on 13 December 2013.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Chronic pain</kwd><kwd>Sternotomy</kwd><kwd>Remifentanil</kwd><kwd>Fentanyl</kwd><kwd>Postoperative pain</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Remifentanil is a pain-relieving drug frequently used during surgery due to its favorable pharmacokinetic and pharmacodynamic properties. It is characterized by rapid onset, predictable rapid recovery profile and dosing reliability
[<xref ref-type="bibr" rid="CR1">1</xref>]. Its use is associated with a shorter length of hospital stay and duration of mechanical ventilation after cardiac surgery and a cardioprotective effect in coronary artery bypass graft (CABG) surgery patients
[<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. On the other hand, high doses of remifentanil administered during surgery have been reported to cause acute postoperative pain and opioid-induced hyperalgesia
[<xref ref-type="bibr" rid="CR4">4</xref>]. Acute postoperative pain, in turn, is a major risk factor for the development of chronic pain
[<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Studies report incidences of chronic thoracic pain after cardiac surgery via sternotomy varying from 11% to 56%, depending on the definition and the study population
[<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. These patients reported significantly lower physical and mental health status compared to patients without chronic thoracic pain
[<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p>Little is known about a possible association between the intraoperative use of remifentanil and the development of chronic pain. A dose-dependent relationship was shown in 90 cardiac patients one year after surgery
[<xref ref-type="bibr" rid="CR15">15</xref>]. Also a randomized study designed to evaluate allodynia after thoracotomy and the occurrence of chronic thoracic pain suggested that there might be an association between the use of high dose remifentanil and increased prevalence of chronic thoracic pain
[<xref ref-type="bibr" rid="CR16">16</xref>]. More recently, a retrospective study found that the combination of remifentanil and sevoflurane was less favorable in terms of chronic pain compared to a propofol and remifentanil combination. Patients with chronic pain had received a significantly higher dose of remifentanil, but significance was not reached in multivariate analysis
[<xref ref-type="bibr" rid="CR17">17</xref>].</p><p>In our hospital, about 60% of cardiac surgery patients receive remifentanil next to fentanyl intraoperatively, depending on the anesthetist&#x02019;s preference
[<xref ref-type="bibr" rid="CR15">15</xref>]. We wonder whether the possible development of hyperalgesia and chronic thoracic pain, with the negative impact on quality of life and cost efficacy, carries the risk of overcoming the advantages of remifentanil.</p><p>So far, however, no prospective randomized controlled trials designed to evaluate the influence of intraoperative remifentanil on the incidence of chronic thoracic pain are available. The current prospective randomized trial is designed to investigate the influence of perioperative additional remifentanil or additional fentanyl on the development of chronic thoracic pain at 3, 6 and 12&#x000a0;months after surgery. In addition, changes in thermal detection thresholds and pain thresholds and the influence of genetic variances will be investigated.</p></sec><sec id="Sec2"><title>Methods/design</title><sec id="Sec3"><title>Study design</title><p>This study is a prospective, randomized, single-blind clinical trial carried out in the St. Antonius Hospital, Nieuwegein, the Netherlands (Figure&#x000a0;
<xref rid="Fig1" ref-type="fig">1</xref>). The study population consists of adult cardiac patients undergoing elective coronary artery bypass (CABG) surgery and/or valve replacement surgery via sternotomy. Patients are blinded for treatment and are randomly assigned to the remifentanil or fentanyl group.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Flowchart of study outline.</bold>
</p></caption><graphic xlink:href="13063_2014_2331_Fig1_HTML" id="d30e536"/></fig></p><p>The study was approved by the local Ethics Committee of this hospital (Verenigde Commissies Mensgebonden Onderzoek (VCMO) R13.013). The study was registered on the Clinical Trials register on 13 December 2013 (ClinicalTrials.gov number NCT02031016). The research coordinator will obtain written informed consent from each participant.</p></sec><sec id="Sec4"><title>Eligibility</title><p>The following inclusion criteria are being applied: (1) patients undergoing cardiac surgery via sternotomy (a CABG and/or valve replacement); and (2) age between 18 and 85&#x000a0;years; (3) weight between 45 and 140&#x000a0;kg. Exclusion criteria are: (1) pregnancy or breastfeeding; (2) language barrier; (3) history of drug abuse; (4) neurologic condition such as peripheral neuropathy and fibromyalgia; (5) known remifentanil, fentanyl, morphine or paracetamol allergy; (6) a body mass index (BMI) above 35&#x000a0;kg/m<sup>2</sup> (7) prior cardiac surgery (re-operations); and (8) patients with chronic pain conditions.</p></sec><sec id="Sec5"><title>Interventions</title><sec id="Sec6"><title>Intraoperative analgesic protocol</title><p>Anesthesia will be induced with midazolam (2.5 to 5.0&#x000a0;mg) followed by a propofol bolus (1 to 2&#x000a0;mg/kg), fentanyl (250 to 500 ug) and pancuronium (0.05-2&#x000a0;mg/kg). After tracheal intubation, patients will be ventilated to normocapnia with oxygen enriched air (50 to 100% oxygen). No nitrous oxide will be used. Sevoflurane will be used as needed. Both groups receive a continuous infusion of propofol (starting dose 200 to 300&#x000a0;mg/hour) and intermittent intravenous fentanyl at predetermined times (that is, before incision, at sternotomy, at aorta cannulation and at opening of the pericardium).</p><p>Patients in the remifentanil group will receive a continuous infusion of remifentanil (starting infusion dose 0.15 ug/kg ideal body weight (IBW)/min) on top of this propofol-fentanyl anesthetic regimen. Patients in the fentanyl group will receive additional boluses of fentanyl 200 to 500&#x000a0;&#x003bc;g as needed instead of the remifentanil infusion.</p><p>Patients in both groups will receive 5 to 10&#x000a0;mg of intravenous morphine 30&#x000a0;minutes before the anticipated end of surgery. After surgery, patients will either go to the Intensive Care Unit (ICU) or to the Post-Anesthesia Care Unit (PACU).</p></sec><sec id="Sec7"><title>Quantitative sensory testing</title><p>One day before surgery, three days after surgery and one year after surgery quantitative sensory testing (QST) will be performed. Cold and warm detection thresholds and pain thresholds will be measured, using the &#x02018;method of limits&#x02019; with the Thermal Sensory Analyzer (TSA) II 2001 (Medoc Advanced Medical Systems, U.S.)
[<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The threshold values will be corrected for age, gender and reaction time. Before the first test session, patients will be asked to practice testing at least twice. A test-retest variability of less than 20% is required before formal pain testing begins. The TSA II has been used extensively to determine warm/cold detection limits and warm/cold pain thresholds.</p></sec><sec id="Sec8"><title>Postoperative treatment</title><p>Patients in both groups will receive the same postoperative treatment. In both the ICU and the PACU, a pain management protocol is in place as part of standard care, consisting of a continuous infusion of morphine (starting dose of 2&#x000a0;mg/hour), which is adapted depending on Numerical Rating Scale (NRS) pain scores, as well as paracetamol four times a day (1&#x000a0;g oral/intravenous)
[<xref ref-type="bibr" rid="CR20">20</xref>]. Any perioperative fentanyl or remifentanil is discontinued at arrival at the ICU or PACU. NRS scores are assessed three times a day and administered medication is registered as part of standard care. On the general postoperative wards, the pain protocol consists of 2.5 to 10&#x000a0;mg morphine (oral/intravenous) on demand and paracetamol four times a day (1&#x000a0;g oral).</p></sec><sec id="Sec9"><title>Follow-up</title><p>After discharge from the hospital, patients will be asked to complete questionnaires 3, 6 and 12&#x000a0;months after surgery. This questionnaire contains questions about pain (perception, location, intensity) based on the Brief Pain Inventory
[<xref ref-type="bibr" rid="CR21">21</xref>] and was described previously
[<xref ref-type="bibr" rid="CR5">5</xref>]. In addition, quality of life (QoL) is measured with the short form (SF)-12 health status instrument, and work productivity and use of health care resources are measured. One year after cardiac surgery, pain thresholds are measured, using the same QST protocol.</p></sec></sec><sec id="Sec10"><title>Primary end point and secondary end points</title><p>The primary end point is the percentage of patients with chronic thoracic pain (NRS &#x0003e;0) one year after cardiac surgery.</p><p>Secondary end points are mean daily acute postoperative NRS scores (0 to 10) and analgesic consumption until discharge from the hospital. Also chronic pain (NRS), Quality of Life, analgesic consumption, work productivity, and use of health care 3, 6 and 12&#x000a0;months after surgery are assessed. In addition, warm/cold detection and pain thresholds (absolute and relative to preoperative values (baseline)) using quantitative sensory testing (QST) are considered. The length of ICU, PACU and hospital stay will be calculated.</p><p>In addition to primary and secondary endpoints, an exploratory screening of different genes in this population will be investigated. The possible influence of different genetic variances that are involved in pain sensitivity (for example, GTP-cyclohydrolase 1 (GCH-1), WDFY family member 4 (WDFY4), Zinc Finger gene Family (ZNF), Melanocortin 1 Receptor (MC1R)) and the pharmacokinetics and pharmacodynamics of opiates (for example, glucuronosyl transferase (UGT), Multidrug Resistance-associated Protein (MRP), mu-opioid receptor gene 1 (OPRM1), Catechol-O-methyltransferase (COMT)) will be explored.</p></sec><sec id="Sec11"><title>Data analysis</title><p>Statistical analyses will be done with The SPSS statistical package (version 22.0 for Windows; SPSS, Chicago, IL). Patient demographics, baseline characteristics and clinical observations are compared between patients receiving remifentanil versus fentanyl during cardiac surgery. Nonparametric data will be expressed as median (range) and analyzed by chi-square. Parametric data will be expressed as mean&#x02009;&#x000b1;&#x02009;SD and analyzed by Student&#x02019;s t-tests or ranks tests.</p><p>The effect of intraoperative use of remifentanil on chronic pain one year after cardiac surgery is analyzed using univariate logistic regression analysis. If baseline characteristics are not balanced, multivariable techniques will be applied. To evaluate the effect of remifentanil versus fentanyl during cardiac surgery on pain thresholds, paired t-tests will be used.</p><p>To estimate the effect of the genotype on the outcome variables, each gene is examined to determine the appropriate model. The gene variants will be coded based on the observed distribution. The outcome parameters are compared between genotypes by a linear mixed model analysis based on the maximum likelihood ratio with the patient genotype status as fixed factors and the time point of outcome parameters as repeated measurement.</p></sec><sec id="Sec12"><title>Sample size calculations</title><p>In a previous study of 90 patients on chronic thoracic pain after cardiac surgery, 15 of the 52 patients who received remifentanil developed chronic thoracic pain (29%) versus 3 of the 38 patients who did not receive remifentanil (8%); resulting in an odds ratio of 4.7
[<xref ref-type="bibr" rid="CR15">15</xref>].</p><p>Rounding numbers, the sample size calculation is made on the assumption that in this prospective study, approximately 30% of the patients receiving remifentanil will develop chronic thoracic pain and that approximately 10% of the patients receiving fentanyl will develop chronic thoracic pain.</p><p>The sample size is calculated with a power of 0.80 and an alpha of 0.05; two sided. A total number of 117 patients are needed. According to previous reports, mortality thirty days after cardiac surgery is approximately 2 to 13.3%
[<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. In a previous study, 8.4% died within one year after surgery
[<xref ref-type="bibr" rid="CR15">15</xref>]. Therefore, the total number of patients needed in this trial is 117 * 1.08&#x02009;=&#x02009;126; 63 patients in each arm.</p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p>This is the first randomized trial that prospectively evaluates the influence of intraoperative remifentanil on the incidence of chronic thoracic pain. Studies in healthy volunteers indicate that remifentanil increases the occurrence of secondary hyperalgesia in experimental pain models
[<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. Other studies have described higher pain levels or analgesic requirements in the acute phase after surgery upon intraoperative use of remifentanil
[<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. The clinical long-term relevance of these mostly short-term increases in pain scores, analgesic requirements or secondary hyperalgesia is unknown.</p><p>The putative biological mechanism by which remifentanil would cause chronic pain is unclear. Opioid-induced hyperalgesia is well described in animal studies but the occurrence in patients is still under debate
[<xref ref-type="bibr" rid="CR31">31</xref>]. Animal studies suggest that remifentanil influences the N-methyl-D-aspartate (NDMA) currents by affecting opioid receptors
[<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Modulation of these NDMA currents could lead to central sensitization and consequently possibly to chronic postoperative pain.</p><p>Ideally, the study design should be double blind and contain no other opioid besides remifentanil. As a study arm without opioids during surgery is obviously unethical, fentanyl was selected for the other arm. The current design, where intermittent fentanyl at predetermined times is combined with continuous propofol as the basis for standardized Total Intravenous Anesthesia (TIVA) in both arms, is based on the design of a previous study investigating risk factors for chronic thoracic pain in our hospital
[<xref ref-type="bibr" rid="CR15">15</xref>]. With one arm randomized to an additional remifentanil infusion and one arm randomized to additional intermittent fentanyl as needed, these two study groups can both be considered the standard of care in our hospital. Given the familiarity with the two study arms, we do not expect unintentional effects from the nonblinding of anesthesiologists and ward nurses. It is emphasized that the patient is kept blinded for the treatment group, which is of particular relevance since it is the patient who determines the primary endpoint, that is, chronic thoracic pain one year after surgery. Another potential design that was considered was a group receiving remifentanil only with another group receiving fentanyl only. While the remifentanil-only group, in particular, cannot be considered a standard of care treatment in our hospital, we underline that when the current design was used in a previous nonrandomized study, a difference in the prevalence of chronic thoracic pain was detected
[<xref ref-type="bibr" rid="CR15">15</xref>].</p><p>In the current study, all patients will be evaluated for their sensory detection and pain thresholds using QST preoperatively, 3&#x000a0;days and 1&#x000a0;year after surgery. This randomized trial in which chronic thoracic pain after cardiac surgery is studied in the remifentanil and control arm is not only an opportunity to investigate the influence of remifentanil on sensory thresholds, but also to explore the influence of cardiac surgery and chronic pain on sensory modalities. Ideally, for this purpose, a pain battery with more than one stimulus (for example, electricity and pressure) should be used; however, in our opinion, use of a large number of pain thresholds measurements is not feasible in patients prior to and 3&#x000a0;days after invasive cardiac surgery.</p><p>The results of this randomized trial may be used to optimize intraoperative analgesia techniques and thereby improve the quality of life of patients after cardiac surgery.</p><sec id="Sec14"><title>Trial status</title><p>The trial is currently enrolling patients. To date, 90% of the patients have been enrolled in the study. The expected average enrollment rate is three to five patients every week. Data collection will stop one year after the last patient is included.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>BMI</term><def><p>body mass index</p></def></def-item><def-item><term>BPI</term><def><p>Brief Pain Inventory</p></def></def-item><def-item><term>CABG</term><def><p>coronary artery bypass graft</p></def></def-item><def-item><term>COMT</term><def><p>catechol-O-methyltransferase</p></def></def-item><def-item><term>GCH-1</term><def><p>GTP-cyclohydrolase 1</p></def></def-item><def-item><term>IBW</term><def><p>ideal body weight</p></def></def-item><def-item><term>ICU</term><def><p>intensive care unit</p></def></def-item><def-item><term>LBW</term><def><p>lean body weight</p></def></def-item><def-item><term>MC1R</term><def><p>melanocortin 1 receptor</p></def></def-item><def-item><term>MRP</term><def><p>multidrug resistance-associated protein</p></def></def-item><def-item><term>NMDA</term><def><p>N-methyl-D-aspartate</p></def></def-item><def-item><term>NRS</term><def><p>Numerical Rating Scale</p></def></def-item><def-item><term>OPRM1</term><def><p>mu-opioid receptor gene 1</p></def></def-item><def-item><term>PACU</term><def><p>post-anesthesia care unit</p></def></def-item><def-item><term>QoL</term><def><p>quality of life</p></def></def-item><def-item><term>QST</term><def><p>quantitative sensory testing</p></def></def-item><def-item><term>SF-12</term><def><p>Short Form-12</p></def></def-item><def-item><term>TSA</term><def><p>thermal sensory analyzer</p></def></def-item><def-item><term>UGT</term><def><p>glucuronosyl transferase</p></def></def-item><def-item><term>WDFY4</term><def><p>WDFY family member 4</p></def></def-item><def-item><term>ZNF</term><def><p>zinc finger gene family.</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>SH, SA, ED, DT, AD, CK designed the study protocol; SH, SA, CK, ED wrote the clinical protocol and obtained authorization from the Ethics Committee and wrote the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>No financial support has been received for this study.</p><p>The authors thank Ko Hagoort for reviewing the manuscript.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derrode</surname><given-names>N</given-names></name><name><surname>Lebrun</surname><given-names>F</given-names></name><name><surname>Levron</surname><given-names>JC</given-names></name><name><surname>Chauvin</surname><given-names>M</given-names></name><name><surname>Debaene</surname><given-names>B</given-names></name></person-group><article-title>Influence of peroperative opioid on postoperative pain after major abdominal surgery: sufentanil TCI versus remifentanil TCI. A randomized, controlled study</article-title><source>Br J Anaesth</source><year>2003</year><volume>91</volume><fpage>842</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1093/bja/aeg263</pub-id><pub-id pub-id-type="pmid">14633756</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>GT</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Ji</surname><given-names>S</given-names></name><name><surname>Irwin</surname><given-names>MG</given-names></name></person-group><article-title>Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial</article-title><source>J Cardiothorac Vasc Anesth</source><year>2010</year><volume>24</volume><fpage>790</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2009.09.012</pub-id><pub-id pub-id-type="pmid">20056436</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>M</given-names></name><name><surname>Landoni</surname><given-names>G</given-names></name><name><surname>Biondi-Zoccai</surname><given-names>G</given-names></name><name><surname>Cabrini</surname><given-names>L</given-names></name><name><surname>Ruggeri</surname><given-names>L</given-names></name><name><surname>Pasculli</surname><given-names>N</given-names></name><name><surname>Giacchi</surname><given-names>V</given-names></name><name><surname>Sayeg</surname><given-names>J</given-names></name><name><surname>Greco</surname><given-names>T</given-names></name><name><surname>Zangrillo</surname><given-names>A</given-names></name></person-group><article-title>Remifentanil in cardiac surgery: a meta-analysis of randomized controlled trials</article-title><source>J Cardiothorac Vasc Anesth</source><year>2012</year><volume>26</volume><fpage>110</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2011.05.007</pub-id><pub-id pub-id-type="pmid">21820920</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>V</given-names></name></person-group><article-title>Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis</article-title><source>Br J Anaesth</source><year>2014</year><volume>112</volume><fpage>991</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1093/bja/aeu137</pub-id><pub-id pub-id-type="pmid">24829420</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gulik</surname><given-names>L</given-names></name><name><surname>Janssen</surname><given-names>LI</given-names></name><name><surname>Ahlers</surname><given-names>SJ</given-names></name><name><surname>Bruins</surname><given-names>P</given-names></name><name><surname>Driessen</surname><given-names>AH</given-names></name><name><surname>van Boven</surname><given-names>WJ</given-names></name><name><surname>van Dongen</surname><given-names>EP</given-names></name><name><surname>Knibbe</surname><given-names>CA</given-names></name></person-group><article-title>Risk factors for chronic thoracic pain after cardiac surgery via sternotomy</article-title><source>Eur J Cardiothorac Surg</source><year>2011</year><volume>40</volume><fpage>1309</fpage><lpage>1313</lpage><pub-id pub-id-type="pmid">21561786</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>TS</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><article-title>Persistent postsurgical pain: risk factors and prevention</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1618</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68700-X</pub-id><pub-id pub-id-type="pmid">16698416</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choiniere</surname><given-names>M</given-names></name><name><surname>Watt-Watson</surname><given-names>J</given-names></name><name><surname>Victor</surname><given-names>JC</given-names></name><name><surname>Baskett</surname><given-names>RJ</given-names></name><name><surname>Bussieres</surname><given-names>JS</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><name><surname>Cogan</surname><given-names>J</given-names></name><name><surname>Costello</surname><given-names>J</given-names></name><name><surname>Feindel</surname><given-names>C</given-names></name><name><surname>Guertin</surname><given-names>MC</given-names></name><name><surname>Racine</surname><given-names>M</given-names></name><name><surname>Taillefer</surname><given-names>MC</given-names></name></person-group><article-title>Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study</article-title><source>CMAJ</source><year>2014</year><volume>186</volume><fpage>E213</fpage><lpage>E223</lpage><pub-id pub-id-type="doi">10.1503/cmaj.131012</pub-id><pub-id pub-id-type="pmid">24566643</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>E</given-names></name><name><surname>Pultorak</surname><given-names>Y</given-names></name><name><surname>Pud</surname><given-names>D</given-names></name><name><surname>Bar-El</surname><given-names>Y</given-names></name></person-group><article-title>Prevalence and characteristics of post coronary artery bypass graft surgery pain (PCP)</article-title><source>Pain</source><year>2001</year><volume>92</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(00)00466-8</pub-id><pub-id pub-id-type="pmid">11323122</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalso</surname><given-names>E</given-names></name><name><surname>Mennander</surname><given-names>S</given-names></name><name><surname>Tasmuth</surname><given-names>T</given-names></name><name><surname>Nilsson</surname><given-names>E</given-names></name></person-group><article-title>Chronic post-sternotomy pain</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>935</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.450803.x</pub-id><pub-id pub-id-type="pmid">11576042</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahtinen</surname><given-names>P</given-names></name><name><surname>Kokki</surname><given-names>H</given-names></name><name><surname>Hynynen</surname><given-names>M</given-names></name></person-group><article-title>Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity</article-title><source>Anesthesiology</source><year>2006</year><volume>105</volume><fpage>794</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1097/00000542-200610000-00026</pub-id><pub-id pub-id-type="pmid">17006079</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gjeilo</surname><given-names>KH</given-names></name><name><surname>Klepstad</surname><given-names>P</given-names></name><name><surname>Wahba</surname><given-names>A</given-names></name><name><surname>Lydersen</surname><given-names>S</given-names></name><name><surname>Stenseth</surname><given-names>R</given-names></name></person-group><article-title>Chronic pain after cardiac surgery: a prospective study</article-title><source>Acta Anaesthesiol Scand</source><year>2010</year><volume>54</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2009.02097.x</pub-id><pub-id pub-id-type="pmid">19681771</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyerson</surname><given-names>J</given-names></name><name><surname>Thelin</surname><given-names>S</given-names></name><name><surname>Gordh</surname><given-names>T</given-names></name><name><surname>Karlsten</surname><given-names>R</given-names></name></person-group><article-title>The incidence of chronic post-sternotomy pain after cardiac surgery&#x02013;a prospective study</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>940</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.450804.x</pub-id><pub-id pub-id-type="pmid">11576043</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>J</given-names></name><name><surname>Drury</surname><given-names>N</given-names></name><name><surname>Poobalan</surname><given-names>AS</given-names></name><name><surname>Jeffrey</surname><given-names>RR</given-names></name><name><surname>Smith</surname><given-names>WC</given-names></name><name><surname>Chambers</surname><given-names>WA</given-names></name></person-group><article-title>The prevalence of chronic chest and leg pain following cardiac surgery: a historical cohort study</article-title><source>Pain</source><year>2003</year><volume>104</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00017-4</pub-id><pub-id pub-id-type="pmid">12855337</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taillefer</surname><given-names>MC</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><name><surname>Belisle</surname><given-names>S</given-names></name><name><surname>Levesque</surname><given-names>S</given-names></name><name><surname>Lanctot</surname><given-names>H</given-names></name><name><surname>Boisvert</surname><given-names>AM</given-names></name><name><surname>Choiniere</surname><given-names>M</given-names></name></person-group><article-title>Prevalence, characteristics, and predictors of chronic nonanginal postoperative pain after a cardiac operation: a cross-sectional study</article-title><source>J Thorac Cardiovasc Surg</source><year>2006</year><volume>131</volume><fpage>1274</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2006.02.001</pub-id><pub-id pub-id-type="pmid">16733157</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gulik</surname><given-names>L</given-names></name><name><surname>Ahlers</surname><given-names>SJ</given-names></name><name><surname>van de Garde</surname><given-names>EM</given-names></name><name><surname>Bruins</surname><given-names>P</given-names></name><name><surname>van Boven</surname><given-names>WJ</given-names></name><name><surname>Tibboel</surname><given-names>D</given-names></name><name><surname>van Dongen</surname><given-names>EP</given-names></name><name><surname>Knibbe</surname><given-names>CA</given-names></name></person-group><article-title>Remifentanil during cardiac surgery is associated with chronic thoracic pain 1&#x000a0;yr after sternotomy</article-title><source>Br J Anaesth</source><year>2012</year><volume>109</volume><fpage>616</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1093/bja/aes247</pub-id><pub-id pub-id-type="pmid">22831889</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salengros</surname><given-names>JC</given-names></name><name><surname>Huybrechts</surname><given-names>I</given-names></name><name><surname>Ducart</surname><given-names>A</given-names></name><name><surname>Faraoni</surname><given-names>D</given-names></name><name><surname>Marsala</surname><given-names>C</given-names></name><name><surname>Barvais</surname><given-names>L</given-names></name><name><surname>Cappello</surname><given-names>M</given-names></name><name><surname>Engelman</surname><given-names>E</given-names></name></person-group><article-title>Different anesthetic techniques associated with different incidences of chronic post-thoracotomy pain: low-dose remifentanil plus presurgical epidural analgesia is preferable to high-dose remifentanil with postsurgical epidural analgesia</article-title><source>J Cardiothorac Vasc Anesth</source><year>2010</year><volume>24</volume><fpage>608</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2009.10.006</pub-id><pub-id pub-id-type="pmid">20005744</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>AR</given-names></name><name><surname>Kwon</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Hong</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name></person-group><article-title>The effects of anesthetics on chronic pain after breast cancer surgery</article-title><source>Anesth Analg</source><year>2013</year><volume>116</volume><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e31827ee372</pub-id><pub-id pub-id-type="pmid">23400991</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolke</surname><given-names>R</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Maier</surname><given-names>C</given-names></name><name><surname>Tolle</surname><given-names>TR</given-names></name><name><surname>Treede</surname><given-names>RD</given-names></name><name><surname>Beyer</surname><given-names>A</given-names></name><name><surname>Binder</surname><given-names>A</given-names></name><name><surname>Birbaumer</surname><given-names>N</given-names></name><name><surname>Birklein</surname><given-names>F</given-names></name><name><surname>Botefur</surname><given-names>IC</given-names></name><name><surname>Braune</surname><given-names>S</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><name><surname>Huge</surname><given-names>V</given-names></name><name><surname>Klug</surname><given-names>R</given-names></name><name><surname>Landwehrmeyer</surname><given-names>GB</given-names></name><name><surname>Magerl</surname><given-names>W</given-names></name><name><surname>Maihofner</surname><given-names>C</given-names></name><name><surname>Rolko</surname><given-names>C</given-names></name><name><surname>Schaub</surname><given-names>C</given-names></name><name><surname>Scherens</surname><given-names>A</given-names></name><name><surname>Sprenger</surname><given-names>T</given-names></name><name><surname>Valet</surname><given-names>M</given-names></name><name><surname>Wasserka</surname><given-names>B</given-names></name></person-group><article-title>Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values</article-title><source>Pain</source><year>2006</year><volume>123</volume><fpage>231</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2006.01.041</pub-id><pub-id pub-id-type="pmid">16697110</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolke</surname><given-names>R</given-names></name><name><surname>Magerl</surname><given-names>W</given-names></name><name><surname>Campbell</surname><given-names>KA</given-names></name><name><surname>Schalber</surname><given-names>C</given-names></name><name><surname>Caspari</surname><given-names>S</given-names></name><name><surname>Birklein</surname><given-names>F</given-names></name><name><surname>Treede</surname><given-names>RD</given-names></name></person-group><article-title>Quantitative sensory testing: a comprehensive protocol for clinical trials</article-title><source>Eur J Pain</source><year>2006</year><volume>10</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.ejpain.2005.02.003</pub-id><pub-id pub-id-type="pmid">16291301</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlers</surname><given-names>SJ</given-names></name><name><surname>van Gulik</surname><given-names>L</given-names></name><name><surname>van Dongen</surname><given-names>EP</given-names></name><name><surname>Bruins</surname><given-names>P</given-names></name><name><surname>van de Garde</surname><given-names>EM</given-names></name><name><surname>van Boven</surname><given-names>WJ</given-names></name><name><surname>Tibboel</surname><given-names>D</given-names></name><name><surname>Knibbe</surname><given-names>CA</given-names></name></person-group><article-title>Efficacy of an intravenous bolus of morphine 2.5 versus morphine 7.5&#x000a0;mg for procedural pain relief in postoperative cardiothoracic patients in the intensive care unit: a randomised double-blind controlled trial</article-title><source>Anaesth Intensive Care</source><year>2012</year><volume>40</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">22577906</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleeland</surname><given-names>CS</given-names></name><name><surname>Ryan</surname><given-names>KM</given-names></name></person-group><article-title>Pain assessment: global use of the Brief Pain Inventory</article-title><source>Ann Acad Med Singapore</source><year>1994</year><volume>23</volume><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">8080219</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>FH</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>Coombs</surname><given-names>LP</given-names></name><name><surname>DeLong</surname><given-names>ER</given-names></name><name><surname>Jamieson</surname><given-names>WR</given-names></name><name><surname>Shroyer</surname><given-names>ALW</given-names></name><name><surname>Grover</surname><given-names>FL</given-names></name></person-group><article-title>Prediction of operative mortality after valve replacement surgery</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>37</volume><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(00)01202-X</pub-id><pub-id pub-id-type="pmid">11693766</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noordzij</surname><given-names>PG</given-names></name><name><surname>Poldermans</surname><given-names>D</given-names></name><name><surname>Schouten</surname><given-names>O</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Schreiner</surname><given-names>FA</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name></person-group><article-title>Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults</article-title><source>Anesthesiology</source><year>2010</year><volume>112</volume><fpage>1105</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181d5f95c</pub-id><pub-id pub-id-type="pmid">20418691</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Koppert</surname><given-names>W</given-names></name><name><surname>Pahl</surname><given-names>I</given-names></name><name><surname>Clark</surname><given-names>DJ</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name></person-group><article-title>Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal</article-title><source>Pain</source><year>2003</year><volume>106</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00276-8</pub-id><pub-id pub-id-type="pmid">14581110</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppert</surname><given-names>W</given-names></name><name><surname>Angst</surname><given-names>M</given-names></name><name><surname>Alsheimer</surname><given-names>M</given-names></name><name><surname>Sittl</surname><given-names>R</given-names></name><name><surname>Albrecht</surname><given-names>S</given-names></name><name><surname>Schuttler</surname><given-names>J</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name></person-group><article-title>Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans</article-title><source>Pain</source><year>2003</year><volume>106</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00294-X</pub-id><pub-id pub-id-type="pmid">14581115</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppert</surname><given-names>W</given-names></name><name><surname>Sittl</surname><given-names>R</given-names></name><name><surname>Scheuber</surname><given-names>K</given-names></name><name><surname>Alsheimer</surname><given-names>M</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Schuttler</surname><given-names>J</given-names></name></person-group><article-title>Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans</article-title><source>Anesthesiology</source><year>2003</year><volume>99</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1097/00000542-200307000-00025</pub-id><pub-id pub-id-type="pmid">12826855</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>H</given-names></name><name><surname>Raeder</surname><given-names>J</given-names></name><name><surname>Draegni</surname><given-names>T</given-names></name><name><surname>Heyerdahl</surname><given-names>F</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Stubhaug</surname><given-names>A</given-names></name></person-group><article-title>Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans</article-title><source>Pain</source><year>2011</year><volume>152</volume><fpage>1289</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2011.02.007</pub-id><pub-id pub-id-type="pmid">21396775</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troster</surname><given-names>A</given-names></name><name><surname>Sittl</surname><given-names>R</given-names></name><name><surname>Singler</surname><given-names>B</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Schuttler</surname><given-names>J</given-names></name><name><surname>Koppert</surname><given-names>W</given-names></name></person-group><article-title>Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans</article-title><source>Anesthesiology</source><year>2006</year><volume>105</volume><fpage>1016</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1097/00000542-200611000-00024</pub-id><pub-id pub-id-type="pmid">17065897</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Stoicea</surname><given-names>N</given-names></name><name><surname>Soghomonyan</surname><given-names>S</given-names></name><name><surname>Bergese</surname><given-names>SD</given-names></name></person-group><article-title>Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review</article-title><source>Front Pharmacol</source><year>2014</year><volume>5</volume><fpage>108</fpage><pub-id pub-id-type="doi">10.3389/fphar.2014.00108</pub-id><pub-id pub-id-type="pmid">24847273</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivosecchi</surname><given-names>RM</given-names></name><name><surname>Rice</surname><given-names>MJ</given-names></name><name><surname>Smithburger</surname><given-names>PL</given-names></name><name><surname>Buckley</surname><given-names>MS</given-names></name><name><surname>Coons</surname><given-names>JC</given-names></name><name><surname>Kane-Gill</surname><given-names>SL</given-names></name></person-group><article-title>An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia</article-title><source>Expert Opin Drug Saf</source><year>2014</year><volume>13</volume><fpage>587</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1517/14740338.2014.902931</pub-id><pub-id pub-id-type="pmid">24669819</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raffa</surname><given-names>RB</given-names></name><name><surname>Pergolizzi</surname><given-names>JV</given-names><suffix>Jr</suffix></name></person-group><article-title>Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?</article-title><source>Pain Manag Nurs</source><year>2013</year><volume>14</volume><fpage>e67</fpage><lpage>e83</lpage><pub-id pub-id-type="doi">10.1016/j.pmn.2011.04.002</pub-id><pub-id pub-id-type="pmid">23972873</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guntz</surname><given-names>E</given-names></name><name><surname>Dumont</surname><given-names>H</given-names></name><name><surname>Roussel</surname><given-names>C</given-names></name><name><surname>Gall</surname><given-names>D</given-names></name><name><surname>Dufrasne</surname><given-names>F</given-names></name><name><surname>Cuvelier</surname><given-names>L</given-names></name><name><surname>Blum</surname><given-names>D</given-names></name><name><surname>Schiffmann</surname><given-names>SN</given-names></name><name><surname>Sosnowski</surname><given-names>M</given-names></name></person-group><article-title>Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord</article-title><source>Anesthesiology</source><year>2005</year><volume>102</volume><fpage>1235</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1097/00000542-200506000-00025</pub-id><pub-id pub-id-type="pmid">15915038</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Joo</surname><given-names>DT</given-names></name></person-group><article-title>Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance</article-title><source>Anesthesiology</source><year>2008</year><volume>109</volume><fpage>308</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31817f4c5d</pub-id><pub-id pub-id-type="pmid">18648240</pub-id></element-citation></ref></ref-list></back></article>